Relative survival analysis quantifies the survival of cancer patients by comparing observed survival in a patient cohort with the expected survival of a comparable segment of the general population.
Survival rates for melanoma can help provide a generic baseline for a person’s outlook. However, several factors play a role in determining outcomes, and the condition will affect each person ...
Graphical Abstract. Relative survival with and without radioiodine therapy (RAI) in intermediate risk papillary thyroid cancer (PTC) and low risk, minimally invasive follicular thyroid cancer (FTC). A ...
Papillary thyroid cancer (PTC) generally has a good prognosis, with 5-year relative survival rates of 99% for regional cancer that has spread to the lymph nodes. PTC is the most common type of thyroid ...
When patients with paroxysmal nocturnal hemoglobinuria (PNH) received eculizumab, survival rates increased and thromboembolic events/major adverse vascular events (TE/MAVE) decreased. Eculizumab ...
Although data from 1975 to 1997 revealed a gap in cancer survival improvement in adolescents and young adults (AYAs; 15-39 years) compared with children and older adults, more recent studies have ...
Please provide your email address to receive an email when new articles are posted on . Estimating risk of mortality for patients with kidney failure is difficult because of other illnesses. Patients ...
The relative survival rate represents the probability of a patient living for another five years, as compared to a random person of the same age, race, and sex. See ...
Survival rates for gallbladder cancer depend on the stage of cancer at the time of diagnosis. In the United States, the combined 5-year relative survival rate across all stages (local, regional, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results